Boxchange and GlaxoSmithKline sign up at Exchange Quay

Excahnge Quay Salford QuaysCanning O’Neill are pleased to announce clients, Hunter Real Estate Investment Managers has secured two lettings bringing the new total of lettings to 11,230 sq ft Exchange Quay in Salford Quays.

GlaxoSmithkline Research & Development Ltd are a global healthcare company, has signed a lease for 9,830 sq ft in Number 4.

Boxchange Associates has signed a lease for 1,400 sq ft. Boxchange are change agents who deliver complex and cross-functional change programmes across all major sectors.

These two new lettings follow hot on the steps from four new lettings totalling over 13,000 sq ft to new occupiers Wurth Electronics and North West Employers, and existing occupiers, international consultancy RPS and marketing agency K2L.

Exchange Quay, purchased by Hunter REIM in 2014, have embarked on a £10m comprehensive refurbishment/ remodelling programme including landscaping and new on-site amenities. Refurbishment of Number 8 has now completed and all the estate works will be finished by June 2015.

Mark Canning, director at Canning O’Neill, said; “We are delighted to have attracted these high-profile occupiers to Exchange Quay and anticipate further deals to follow as we get closer to completion of the remodelling works.”

Andrew Moffat, fund manager at Hunter, said; “The addition of two new occupiers to Exchange Quay shows a continued commitment to the new-look development. Work is progressing well on-site and we look forward to welcoming and retaining more occupiers in due course.”

Requirements from 600 sq ft up to 50,000 sq ft can be accommodated within the 8 buildings on the scheme.

For details of offices to let Salford Quays, contact the team at Canning O’Neill on 0161 244 5500.